These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12565933)

  • 21. Structure-based approach for the study of thyroid hormone receptor binding affinity and subtype selectivity.
    Wang FF; Yang W; Shi YH; Cheng XR; Le GW
    J Biomol Struct Dyn; 2016 Oct; 34(10):2251-67. PubMed ID: 26510472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two consecutive nucleotide substitutions resulting in the T3 receptor beta gene resulting in an 11-amino acid truncation in a patient with generalized resistance to thyroid hormone.
    Miyoshi Y; Nakamura H; Sasaki S; Tagami T; Misaki T; Konishi J; Nakao K
    Mol Cell Endocrinol; 1995 Oct; 114(1-2):9-17. PubMed ID: 8674855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of thyroid hormone action: insights from X-ray crystallographic and functional studies.
    Ribeiro RC; Apriletti JW; Wagner RL; West BL; Feng W; Huber R; Kushner PJ; Nilsson S; Scanlan T; Fletterick RJ; Schaufele F; Baxter JD
    Recent Prog Horm Res; 1998; 53():351-92; discussion 392-4. PubMed ID: 9769715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thyroid hormone receptor-beta mutants associated with generalized resistance to thyroid hormone show defects in their ligand-sensitive repression function.
    Piedrafita FJ; Ortiz MA; Pfahl M
    Mol Endocrinol; 1995 Nov; 9(11):1533-48. PubMed ID: 8584031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5-Aryluracils as potent GnRH antagonists-Characterization of atropisomers.
    Zhao L; Guo Z; Chen Y; Hu T; Wu D; Zhu YF; Rowbottom M; Gross TD; Tucci FC; Struthers RS; Xie Q; Chen C
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3344-9. PubMed ID: 18442905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimization of the physicochemical and pharmacokinetic attributes in a 6-azauracil series of P2X7 receptor antagonists leading to the discovery of the clinical candidate CE-224,535.
    Duplantier AJ; Dombroski MA; Subramanyam C; Beaulieu AM; Chang SP; Gabel CA; Jordan C; Kalgutkar AS; Kraus KG; Labasi JM; Mussari C; Perregaux DG; Shepard R; Taylor TJ; Trevena KA; Whitney-Pickett C; Yoon K
    Bioorg Med Chem Lett; 2011 Jun; 21(12):3708-11. PubMed ID: 21565499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A structural role for hormone in the thyroid hormone receptor.
    Wagner RL; Apriletti JW; McGrath ME; West BL; Baxter JD; Fletterick RJ
    Nature; 1995 Dec; 378(6558):690-7. PubMed ID: 7501015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective thyromimetics. Cardiac-sparing thyroid hormone analogues containing 3'-arylmethyl substituents.
    Leeson PD; Emmett JC; Shah VP; Showell GA; Novelli R; Prain HD; Benson MG; Ellis D; Pearce NJ; Underwood AH
    J Med Chem; 1989 Feb; 32(2):320-36. PubMed ID: 2913295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro effect of Triac on resistance to thyroid hormone receptor mutants: potential basis for therapy.
    Messier N; Laflamme L; Hamann G; Langlois MF
    Mol Cell Endocrinol; 2001 Mar; 174(1-2):59-69. PubMed ID: 11306172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Basal and thyroid hormone receptor auxiliary protein-enhanced binding of thyroid hormone receptor isoforms to native thyroid hormone response elements.
    Yen PM; Darling DS; Chin WW
    Endocrinology; 1991 Dec; 129(6):3331-6. PubMed ID: 1954909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Only subtle protein conformational adaptations are required for ligand binding to thyroid hormone receptors: simulations using a novel multipoint steered molecular dynamics approach.
    Martínez L; Polikarpov I; Skaf MS
    J Phys Chem B; 2008 Aug; 112(34):10741-51. PubMed ID: 18681473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A TATA binding protein-associated factor functions as a coactivator for thyroid hormone receptors.
    Petty KJ; Krimkevich YI; Thomas D
    Mol Endocrinol; 1996 Dec; 10(12):1632-45. PubMed ID: 8961272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thyroid receptor ligands. Part 7: Indirect antagonists of the thyroid hormone receptor with improved affinity.
    Malm J; Gordon S; Brandt P; Carlsson B; Agback P; Bäckbro Saeidi A; Sandberg J
    Bioorg Med Chem Lett; 2007 Apr; 17(7):2018-21. PubMed ID: 17254783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isoform variable action among thyroid hormone receptor mutants provides insight into pituitary resistance to thyroid hormone.
    Safer JD; Langlois MF; Cohen R; Monden T; John-Hope D; Madura J; Hollenberg AN; Wondisford FE
    Mol Endocrinol; 1997 Jan; 11(1):16-26. PubMed ID: 8994184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 3-hydroxypyridazine 1-oxides as carboxylate bioisosteres: a new series of subtype-selective AMPA receptor agonists.
    Greenwood JR; Mewett KN; Allan RD; Martín BO; Pickering DS
    Neuropharmacology; 2006 Jul; 51(1):52-9. PubMed ID: 16631211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A natural transactivation mutation in the thyroid hormone beta receptor: impaired interaction with putative transcriptional mediators.
    Collingwood TN; Rajanayagam O; Adams M; Wagner R; Cavaillès V; Kalkhoven E; Matthews C; Nystrom E; Stenlof K; Lindstedt G; Tisell L; Fletterick RJ; Parker MG; Chatterjee VK
    Proc Natl Acad Sci U S A; 1997 Jan; 94(1):248-53. PubMed ID: 8990194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thyroid receptor ligands. 3. Design and synthesis of 3,5-dihalo-4-alkoxyphenylalkanoic acids as indirect antagonists of the thyroid hormone receptor.
    Hedfors A; Appelqvist T; Carlsson B; Bladh LG; Litten C; Agback P; Grynfarb M; Koehler KF; Malm J
    J Med Chem; 2005 May; 48(9):3114-7. PubMed ID: 15857115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cigarette Smoke Extract Disrupts Transcriptional Activities Mediated by Thyroid Hormones and Its Receptors.
    Hayashi M; Futawaka K; Matsushita M; Hatai M; Yoshikawa N; Nakamura K; Tagami T; Moriyama K
    Biol Pharm Bull; 2018; 41(3):383-393. PubMed ID: 29491215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutant-selective thyromimetics for the chemical rescue of thyroid hormone receptor mutants associated with resistance to thyroid hormone.
    Shi Y; Ye H; Link KH; Putnam MC; Hubner I; Dowdell S; Koh JT
    Biochemistry; 2005 Mar; 44(12):4612-26. PubMed ID: 15779888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Triiodothyroacetic acid has unique potential for therapy of resistance to thyroid hormone.
    Takeda T; Suzuki S; Liu RT; DeGroot LJ
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2033-40. PubMed ID: 7608251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.